SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001193125-23-023821
Filing Date
2023-02-03
Accepted
2023-02-03 13:04:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 6547
  Complete submission text file 0001193125-23-023821.txt   7463
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)